Impact of neutrophil/lymphocytes ratio on the prognosis in breast cancer patients who underwent modified radical mastectomy
10.3969/j.issn.1009-9905.2017.10.001
- VernacularTitle:术前中性粒细胞与淋巴细胞比值对乳腺癌改良根治术预后的影响
- Author:
Xiao-Dan LIU
1
;
Chen-Guang LÜ
;
Yao QIN
;
Xue-Feng ZHANG
Author Information
1. 沈阳军区总医院普通外科 辽宁沈阳 110084
- Keywords:
Breast cancer;
Neutrophil-Lymphocytes Ratio;
Surgery;
Prognosis
- From:
Chinese Journal of Current Advances in General Surgery
2017;20(10):757-760
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To purpose of this study is to introduce how peripheral blood neutrophil/lymphocyte ratio (NLR) before operations influences the prognosis of patients with breast cancer.Methods:Review of systems were used to analyze patients who suffered from breast cancer and accepted modified radical mastectomy of breast cancer according to the clinical data of 180 cases of Shenyang Military Region General Hospital between January 2002 and January 2005.All the patients were classified into two groups according to the NLR with the critical value at 6.0.2 statistics were used to evaluate the relationship between NLR of two groups and clinical pathological characteristic.Kaplan-Meier survival analysis and Cox's proportional hazards regression model were used to analyze the relationship among NLR of two groups,other clinical pathologic characteristic and prognosis of patients.Results:The high level of NLR is related with the size of patients' tumor,lymph node metastasis and TNM stages (P＜0.05).Kaplan-Meier survival curves indicated the group of high level of NLR's overall survival (OS) and disease-free survival (DFS) was significantly lower than the low level NLR group (P＜0.05).Single factor and multivariate cox's proportional hazards regression model indicated the high level of NLR before operations,the size of tumor,lymph node metastasis and TNM stages were significantly related with the OS and DFS (P＜0.05).Conclusion:The high level of NLR before operations is an independent risk factor to influence the OS and DFS of the patients who accepted modified radical mastectomy of breast cancer.
